Synergy-1 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	2

97. 潰瘍性大腸炎

---

臨床試験数 : 2,630 /  薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02865707 (ClinicalTrials.gov)	August 2016	12/7/2016	Ulcerative Colitis Relapse Prevention by Prebiotics	Prevention of Ulcerative Colitis by Prebiotics: Efficacy and Protective Mechanisms	Ulcerative Colitis	Dietary Supplement: Synergy-1;Dietary Supplement: Maltodextrin	University of Alberta	University of British Columbia	Completed	18 Years	75 Years	All	89	N/A	Canada
2	NCT02093767 (ClinicalTrials.gov)	August 2007	19/3/2014	Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis	Open-Label Trial of a Prebiotic Preparation Containing Inulin and Oligofructose (Synergy-1) for the Treatment of Mild to Moderate Acute Ulcerative Colitis	Ulcerative Colitis	Dietary Supplement: Synergy1	University of Alberta	Canadian Institutes of Health Research (CIHR);Crohn's and Colitis Canada;Beneo GmbH	Completed	18 Years	65 Years	All	24	N/A	Canada